Re-infections with SARS-CoV-2 require a clarification of favourable risk factors

被引:0
作者
Finsterer, Josef [1 ]
机构
[1] Neurol & Neurophysiol Ctr, Vienna, Austria
关键词
SARS-CoV-2; Re-infection; Methylprednisolone; COVID-19;
D O I
10.1186/s43162-023-00260-x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:2
相关论文
共 4 条
[1]   The roles of methylprednisolone treatment in patients with COVID-19: A systematic review and meta-analysis [J].
Hong, Shukun ;
Wang, Hongye ;
Zhang, Zhaolong ;
Qiao, Lujun .
STEROIDS, 2022, 183
[2]   Safety and efficacy of methylprednisolone versus dexamethasone in critically ill patients with COVID-19 acute respiratory distress syndrome: a retrospective study [J].
Kellogg, Dean ;
Gutierrez, G. Christina ;
Small, Clay E. E. ;
Stephens, Benjamin ;
Sanchez, Paloma ;
Beg, Moezzullah ;
Keyt, Holly L. L. ;
Restrepo, Marcos I. I. ;
Attridge, Rebecca L. L. ;
Maselli, Diego J. J. .
THERAPEUTIC ADVANCES IN INFECTIOUS DISEASE, 2023, 10
[3]   A case of reinfection with a different variant of SARS-CoV-2: case report [J].
Shimada, Nagashige ;
Shinoda, Masahiro ;
Takei, Hiroaki ;
Yoshida, Yuto ;
Nishimura, Masashi ;
Kousaka, Mio ;
Morikawa, Miwa ;
Sato, Takashi ;
Matsuse, Hiroto ;
Shinkai, Masaharu .
EGYPTIAN JOURNAL OF INTERNAL MEDICINE, 2023, 35 (01)
[4]   Impact of systemic corticosteroids on hospital length of stay among patients with COVID-19 [J].
Zamarron, Ester ;
Carpio, Carlos ;
Villamanan, Elena ;
Alvarez-Sala, Rodolfo ;
Borobia, Alberto M. ;
Gomez-Carrera, Luis ;
Buno, Antonio ;
Prados, Concepcion .
FARMACIA HOSPITALARIA, 2023, 47 (02) :55-63